Finally, we used targeted NGS to identify the presence of RCC specific mutations, such as VHL, or other cancer specific alterations in samples from different tumour grades and matched healthy tissue which had been grown in the stiff 3D cultures. The gene discussed is VHL; the disease is renal cell carcinoma.